Found: 17
Select item for more details and to access through your institution.
Proposed mechanism of off-target toxicity for antibody-drug conjugates driven by mannose receptor uptake.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 217, doi. 10.1007/s00262-012-1369-3
- By:
- Publication type:
- Article
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 347, doi. 10.1007/s00262-012-1331-4
- By:
- Publication type:
- Article
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 285, doi. 10.1007/s00262-012-1334-1
- By:
- Publication type:
- Article
Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 393, doi. 10.1007/s00262-012-1323-4
- By:
- Publication type:
- Article
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 337, doi. 10.1007/s00262-012-1340-3
- By:
- Publication type:
- Article
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 321, doi. 10.1007/s00262-012-1342-1
- By:
- Publication type:
- Article
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 371, doi. 10.1007/s00262-012-1338-x
- By:
- Publication type:
- Article
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 383, doi. 10.1007/s00262-012-1343-0
- By:
- Publication type:
- Article
T cell profiling reveals high CD4CTLA-4 T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 245, doi. 10.1007/s00262-012-1330-5
- By:
- Publication type:
- Article
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 309, doi. 10.1007/s00262-012-1341-2
- By:
- Publication type:
- Article
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 225, doi. 10.1007/s00262-012-1324-3
- By:
- Publication type:
- Article
Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 299, doi. 10.1007/s00262-012-1332-3
- By:
- Publication type:
- Article
Chemoimmunotherapy: reengineering tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 203, doi. 10.1007/s00262-012-1388-0
- By:
- Publication type:
- Article
Tumor-specific CD4 T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 257, doi. 10.1007/s00262-012-1329-y
- By:
- Publication type:
- Article
The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 237, doi. 10.1007/s00262-012-1328-z
- By:
- Publication type:
- Article
CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 273, doi. 10.1007/s00262-012-1333-2
- By:
- Publication type:
- Article
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 359, doi. 10.1007/s00262-012-1336-z
- By:
- Publication type:
- Article